¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Drug Eluting Balloon Market, By Product Type, By Technology, By End User, By Geography
»óǰÄÚµå : 1673913
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,215,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,668,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,812,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀåÀº 2025³â¿¡ 7¾ï 7,680¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 14¾ï 280¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ CAGR 8.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 7¾ï 7,680¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 8.80% 2032³â ±Ý¾× ¿¹Ãø 14¾ï 280¸¸ ´Þ·¯
µµÇ¥. 2025³â Áö¿ªº° ¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀå Á¡À¯À²(%)
Drug Eluting Balloon Market-IMG1

¾à¹°¿ëÃâÇü dz¼±Àº Ç÷°ü¼ºÇü¼ú ÈÄ µ¿¸Æ ÇùÂøÀ» ¿¹¹æÇÏ¿© °ü»óµ¿¸ÆÁúȯ Ä¡·á¿¡ ÀÖÀ¸¸ç, ¾à¹°¿ëÃâÇü ½ºÅÙÆ®¸¦ ´ëüÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ ´ë¾ÈÀ¸·Î ¼Ò°³µÇ°í ÀÖ½À´Ï´Ù. ¾à¹°¿ëÃâÇü dz¼±Àº ÆÄŬ¸®Å¹¼¿°ú °°Àº Ç×Áõ½ÄÁ¦¸¦ dz¼± Ä«Å×ÅÍÀÇ ¹Ì¼¼ÇÑ ±¸¸ÛÀ» ÅëÇØ Ç÷°üº®¿¡ Á÷Á¢ Àü´ÞÇÕ´Ï´Ù. À̸¦ ÅëÇØ °úµµÇÑ ½Å»ý ³»¸· °úÇü¼ºÀ» ¾ïÁ¦ÇÏ¿© ÀçÇùÂøÀÇ À§ÇèÀ» °¨¼Ò½Ãŵ´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀ» ¾Î°í ÀÖ´Â ³ëÀÎ Áõ°¡, ¸»Ãʵ¿¸Æ ÁúȯÀ¸·Î À̾îÁö´Â ´ç´¢º´ ȯÀÚ Áõ°¡, ¾à¹°Àü´Þ dz¼± Ä«Å×ÅÍÀÇ ±â¼ú ¹ßÀü, ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ Ã¤Åà Áõ°¡ µîÀº °¡±î¿î ¹Ì·¡¿¡ ¾àÁ¦¿ëÃ⼺ dz¼±¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¾à¹°¿ëÃâÇü dz¼± ¼¼°è ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº Ç÷°ü¼ºÇü¼ú Ä¡·á¸¦ ÇÊ¿ä·Î ÇÏ´Â ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀº Àü ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î ¿¬°£ 1,700¸¸ ¸í ÀÌ»óÀÌ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿¸Æ Áúȯ¿¡ Ãë¾àÇÑ ³ë³âÃþ Áõ°¡´Â ¾àÁ¦¿ëÃ⼺ dz¼±¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ¾à¹°¿ëÃ⼺ dz¼±Àº ÀÏ¹Ý Ç³¼±À̳ª ¾à¹°¿ëÃ⼺ ½ºÅÙÆ®¿¡ ºñÇØ ºñ¿ëÀÌ ºñ½Î±â ¶§¹®¿¡ °¡°Ý¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼­ÀÇ Ã¤Åÿ¡´Â ÇѰ谡 ÀÖ½À´Ï´Ù. »õ·Î¿î ¾à¹°Àü´Þ ½Ã½ºÅÛ, »ýºÐÇØ¼º °íºÐÀÚ °³¹ß, ¹èÇÕ Á¦Ç° ¹èÇÕ µîÀÇ ¿¬±¸°³¹ßÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ ¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀå, ±â¼úº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ ¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ ¾àÁ¦¿ëÃ⼺ dz¼± ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ ±ÇÀå»çÇ×

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Drug Eluting Balloon Market is estimated to be valued at USD 776.8 Mn in 2025 and is expected to reach USD 1,402.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 776.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.80% 2032 Value Projection: USD 1,402.8 Mn
Figure. Drug Eluting Balloon Market Share (%), By Region 2025
Drug Eluting Balloon Market - IMG1

Drug eluting balloons offer an effective alternative to drug eluting stents for treating coronary artery disease by preventing the narrowing of arteries post angioplasty. These work by delivering anti-proliferative drugs like paclitaxel directly to the blood vessel walls through microscopic pores in the balloon catheter. This inhibit excessive neointimal hyperplasia and reduces the risk of restenosis. Growing geriatric population suffering from cardiovascular diseases, increasing incidences of diabetes leading to peripheral artery disease, technological advancements in drug delivery balloon catheters, and rising adoption of minimally invasive procedures can boost demand for drug eluting balloons in the near future.

Market Dynamics:

Global drug eluting balloon market growth is driven by rising prevalence of cardiovascular diseases requiring angioplasty treatments. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, responsible for over 17 million deaths annually. Moreover, growing elderly population that is more susceptible to arterial diseases boosts demand for drug eluting balloons. However, high costs associated with drug eluting balloons compared to plain old balloons and drug eluting stents limit their adoption in price sensitive markets. Ongoing research and development activities to develop novel drug delivery systems, biodegradable polymers, and formulate combination products offers lucrative opportunities for market players.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Drug Eluting Balloon Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global Drug Eluting Balloon Market, By Product Type, 2020 - 2032, (USD Mn)

6. Global Drug Eluting Balloon Market, By Technology, 2020 - 2032, (USD Mn)

7. Global Drug Eluting Balloon Market, By End User, 2020 - 2032, (USD Mn)

8. Global Drug Eluting Balloon Market, By Region, 2020 - 2032, (USD Mn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â